DK0693070T3 - Pyrido[2,3-b][1,4]benzodiazepinoner som M2-receptorligand til behandling af neurologiske lidelser - Google Patents
Pyrido[2,3-b][1,4]benzodiazepinoner som M2-receptorligand til behandling af neurologiske lidelserInfo
- Publication number
- DK0693070T3 DK0693070T3 DK94914039T DK94914039T DK0693070T3 DK 0693070 T3 DK0693070 T3 DK 0693070T3 DK 94914039 T DK94914039 T DK 94914039T DK 94914039 T DK94914039 T DK 94914039T DK 0693070 T3 DK0693070 T3 DK 0693070T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- neurological disorders
- benzodiazepinones
- pyrido
- receptor ligand
- Prior art date
Links
- 208000012902 Nervous system disease Diseases 0.000 title abstract 2
- 208000025966 Neurological disease Diseases 0.000 title abstract 2
- 239000003446 ligand Substances 0.000 title abstract 2
- 102000017926 CHRM2 Human genes 0.000 title 1
- 101150012960 Chrm2 gene Proteins 0.000 title 1
- LDZJARBEIDPEEY-UHFFFAOYSA-N pyrido[2,3-b][1,4]benzodiazepin-2-one Chemical class C1=C2C=CC=CC2=NC2=NC(=O)C=CC2=N1 LDZJARBEIDPEEY-UHFFFAOYSA-N 0.000 title 1
- 102000007205 Muscarinic M2 Receptor Human genes 0.000 abstract 1
- 108010008407 Muscarinic M2 Receptor Proteins 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4287293A | 1993-04-05 | 1993-04-05 | |
| PCT/US1994/003720 WO1994022861A1 (en) | 1993-04-05 | 1994-04-05 | PYRIDO[2,3-b][1,4]BENZODIAZEPINONES AS M2 RECEPTOR LIGAND FOR THE TREATMENT OF NEUROLOGICAL DISORDERS |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0693070T3 true DK0693070T3 (da) | 2002-11-11 |
Family
ID=21924192
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94914039T DK0693070T3 (da) | 1993-04-05 | 1994-04-05 | Pyrido[2,3-b][1,4]benzodiazepinoner som M2-receptorligand til behandling af neurologiske lidelser |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US5712269A (da) |
| EP (2) | EP0693070B1 (da) |
| JP (1) | JP3638950B2 (da) |
| AT (1) | ATE221067T1 (da) |
| AU (1) | AU688318B2 (da) |
| CA (1) | CA2159815A1 (da) |
| DE (1) | DE69431050T2 (da) |
| DK (1) | DK0693070T3 (da) |
| ES (1) | ES2180575T3 (da) |
| PT (1) | PT693070E (da) |
| WO (1) | WO1994022861A1 (da) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6528529B1 (en) | 1998-03-31 | 2003-03-04 | Acadia Pharmaceuticals Inc. | Compounds with activity on muscarinic receptors |
| ITMI991452A1 (it) * | 1999-07-01 | 2001-01-01 | Mediolanum Farmaceutici Srl | Antagonisti selettivi per i recettori m2 con struttura 5h-dibenzo b,fazepinica |
| AR025884A1 (es) * | 1999-10-01 | 2002-12-18 | Takeda Pharmaceutical | Compuestos de amina ciclica, su produccion y su uso |
| EP1498138A1 (en) * | 2002-04-19 | 2005-01-19 | Takeda Pharmaceutical Company Limited | Preventives for hiv infection |
| WO2006008118A1 (en) | 2004-07-16 | 2006-01-26 | Proteosys Ag | Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents |
| EP2258359A3 (en) | 2005-08-26 | 2011-04-06 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation with sabcomelin |
| EP1928437A2 (en) | 2005-08-26 | 2008-06-11 | Braincells, Inc. | Neurogenesis by muscarinic receptor modulation |
| RU2765463C2 (ru) * | 2008-12-04 | 2022-01-31 | Чунси ЮЙ | Композиции интенсивного проникновения и их применение |
| EP2379080A1 (en) | 2009-01-13 | 2011-10-26 | ProteoSys AG | Pirenzepine as otoprotective agent |
| GB201510010D0 (en) | 2015-06-09 | 2015-07-22 | King S College London | PDD and BPD compounds |
| GB201514928D0 (en) | 2015-08-21 | 2015-10-07 | King S College London | PDD compounds |
| US20180339985A1 (en) | 2015-08-21 | 2018-11-29 | Femtogenix Limited | Pdd compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH438343A (de) * | 1962-11-08 | 1967-06-30 | Thomae Gmbh Dr K | Verfahren zur Herstellung von 5,6-Dihydro-6-oxo-11H-pyrido (2,3-b) (1,4)-benzodiazepinen |
| DE3735895A1 (de) * | 1987-10-23 | 1989-05-03 | Thomae Gmbh Dr K | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE3818299A1 (de) * | 1988-05-30 | 1989-12-07 | Thomae Gmbh Dr K | Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| GB9000302D0 (en) * | 1990-01-06 | 1990-03-07 | Pfizer Ltd | Muscarinic receptor antagonists |
| DE4112014A1 (de) * | 1991-04-12 | 1992-10-15 | Thomae Gmbh Dr K | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel zur behandlung von erkrankungen des zentralnervensystems und zur foerderung der cerebralen durchblutung |
-
1994
- 1994-04-05 AU AU66261/94A patent/AU688318B2/en not_active Ceased
- 1994-04-05 PT PT94914039T patent/PT693070E/pt unknown
- 1994-04-05 ES ES94914039T patent/ES2180575T3/es not_active Expired - Lifetime
- 1994-04-05 EP EP94914039A patent/EP0693070B1/en not_active Expired - Lifetime
- 1994-04-05 DK DK94914039T patent/DK0693070T3/da active
- 1994-04-05 EP EP01200454A patent/EP1120416A1/en not_active Withdrawn
- 1994-04-05 AT AT94914039T patent/ATE221067T1/de not_active IP Right Cessation
- 1994-04-05 WO PCT/US1994/003720 patent/WO1994022861A1/en active IP Right Grant
- 1994-04-05 DE DE69431050T patent/DE69431050T2/de not_active Expired - Fee Related
- 1994-04-05 CA CA002159815A patent/CA2159815A1/en not_active Abandoned
- 1994-04-05 JP JP52246994A patent/JP3638950B2/ja not_active Expired - Fee Related
-
1995
- 1995-01-24 US US08/377,667 patent/US5712269A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE221067T1 (de) | 2002-08-15 |
| DE69431050T2 (de) | 2003-03-13 |
| JPH08510999A (ja) | 1996-11-19 |
| JP3638950B2 (ja) | 2005-04-13 |
| ES2180575T3 (es) | 2003-02-16 |
| AU688318B2 (en) | 1998-03-12 |
| US5712269A (en) | 1998-01-27 |
| EP0693070B1 (en) | 2002-07-24 |
| PT693070E (pt) | 2002-12-31 |
| EP0693070A1 (en) | 1996-01-24 |
| EP1120416A1 (en) | 2001-08-01 |
| DE69431050D1 (de) | 2002-08-29 |
| WO1994022861A1 (en) | 1994-10-13 |
| CA2159815A1 (en) | 1994-10-13 |
| AU6626194A (en) | 1994-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ330023A (en) | Fused pyrrolecarboxanilides and their use as a GABA brain receptor ligands | |
| FI20020059L (fi) | Enantiomeeripuhtaat diatsabisyklo/4.3.0/nonaanijohdannaiset | |
| DZ2370A1 (fr) | Procédé de préparation d'hydrocarbures | |
| DK0693070T3 (da) | Pyrido[2,3-b][1,4]benzodiazepinoner som M2-receptorligand til behandling af neurologiske lidelser | |
| BG95241A (bg) | Метод за получаване на 2,9-дизаместени-4н-пиридо/1.2-а/ пиримидин-4-они | |
| AU7983691A (en) | 1h-substituted-imidazo{4,5-d}pyridazine compounds for treatment of cardiovascular disorders | |
| NO180587C (no) | Fremgangsmåte for fremstilling av 5-substituerte pyrrolo(2,3-d)pyrimidiner | |
| ATE178332T1 (de) | Benzothiadiazinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zuzammensetzungen | |
| AU2338992A (en) | Carbonate-substituted imidazo(4,5-d) pyridazine compounds for treatment of cardiovascular disorders | |
| WO1999024026A3 (en) | Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds | |
| AU7346694A (en) | Method for preparing photochromic compounds of the spiro{indolin-{2,3'}-benzoxazine} ringed type | |
| FR2721598B1 (fr) | Procédé de préparation de catalyseurs d'ammoxydation. | |
| DK0935598T3 (da) | 5-heteroatom-alkylsubstituerede 3-oxopyrido(1,2-a)benzimidazol-4-carboxamidderivater egnede til behandling af sygdomme i centralnervesystemet | |
| DZ2202A1 (fr) | Procédé de préparation d'énantiomères purs d'acides cyclo-alcano-indol-azaindol-et pyrimido (1,2-a) indol-carbocyclique et leurs dérivés actives. | |
| FR2708266B1 (fr) | Procédé de préparation d'alcanesulfonamides. | |
| ZA963132B (en) | Process for the preparation of pure enantiomers of 1-2-pyridyl)-2-cyclo-hexylethylamine. | |
| DZ2619A1 (fr) | Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoïques substitués. | |
| DZ2423A1 (fr) | Procédé pour la préparation d'acides 4-phényl-4-cyanocyclohexanoiques substitués. | |
| DK0612745T3 (da) | Fremgangsmåde til fremstilling af 1,2,3,4,10,14b-hexahydro-2-methyl-dibenzo[c,f]pyrazino[1,2-a]azepin og salte deraf | |
| PH24501A (en) | Substituted 3-phenyl-7h-thiazolo(3,2-b)(1,2,4)triazin-7-ones | |
| PT889044E (pt) | Derivados do 5-(heteroaril)alquil-3-oxo-pirido-(1,2-a)benzimidazole-4-carboxamida (pbi) uteis no tratamento de perturbacoes do sistema nervoso central | |
| IT1296613B1 (it) | Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide. | |
| FR2695388B1 (fr) | Dérivés de 1,3,4-benzotriazépin-5(4H)-one et procédé pour leur préparation. | |
| FI943706A0 (fi) | Menetelmä kiraalisen etyyli-(5-amino-1,2-dihydro-2-metyyli-3-fenyylipyrido(3,4-b)pyratsin-7-yyli)karbamaatin valmistamiseksi | |
| EP0462468A3 (en) | 9-amino-2-phenylbicyclo(3.3.1)nonane and 9-amino-2-phenylbicyclo(3.3.1)-non-2-ene and therapeutic agents containing them |